India Issues Urgent Warning as Affordable Weight-Loss Drug Generics Hit the Market
India’s health authorities have issued a critical warning about the potential dangers of unregulated use of weight-loss drugs, as low-cost generic versions of semaglutide—the key ingredient in popular medications like Ozempic and Wegovy—become widely available. This development comes in the wake of patent expiration on March 20, 2026, positioning India, the world’s largest supplier of […]
Continue Reading